About Dylan Smith

This author has not yet filled in any details.
So far Dylan Smith has created 41 blog entries.

CDC Warns of Supply Shortage for COVID-19 Rapid Tests

In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing

By |2021-09-20T12:01:49-04:00September 2nd, 2021|Categories: News|0 Comments

NJ DOH issues guidance for SARS-CoV-2 positive specimen in cases of vaccine breakthrough and reinfection

The New Jersey Department of Health has asked for all healthcare providers and long-term care facilities in the state to alert them of SARS‐CoV‐2 positive respiratory specimens when vaccine failure is suspected so that genomic sequencing can be performed. Per the guidance: “Because most commercial laboratories retain respiratory specimens only a couple days, once

By |2021-09-20T11:58:54-04:00July 16th, 2021|Categories: News|0 Comments

Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

Respiratory tract infection is one of the most frequent and fatal infections in the geriatric population. Long-term Care Facilities (LTCF) residents are prone to infection because of the decrease in their immunity, their impaired cognitive function, frailty, congregated setting, the kinds of medication taken, and the presence of many underlying factors like diabetes or kidney

By |2021-07-07T11:45:38-04:00July 7th, 2021|Categories: Quarterly Letter|Comments Off on Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

Aculabs prepares for national shortage of Sodium Citrate Tubes

Over the past 6 months, there has been unprecedented demand for Sodium Citrate tubes due to the COVID-19 pandemic and alternative vendor supply challenges. Due to their use in monitoring a person's clotting time, especially if they are on blood thinners such as Coumadin, they are a staple in delivering diagnostic services to long-term care

By |2021-07-01T10:05:12-04:00June 30th, 2021|Categories: News|0 Comments

CAP ranks Aculabs as Deficiency-Free in 2021 Inspection

During the week of Monday, May 10th, 2021, Aculabs was happy to open our doors to be inspected for continued accreditation by representatives from The College of American Pathologists. The College of American Pathologists describes its accreditation curriculum as follows on its website: The College of American Pathologists (CAP's) Laboratory Accreditation Program accredits the entire spectrum

By |2021-05-28T12:24:39-04:00May 28th, 2021|Categories: News|0 Comments

New Jersey OEM Extends Expiration Date on BinaxNOW Cards

Over the course of the last six months, Aculabs has helped the New Jersey Department of Health by assisting with the distribution of the BinaxNOWTM COVID-19 Ag test cards. Throughout the pilot program, Aculabs has helped to distribute over 1 Million of the test cards on behalf of the New Jersey Department of Health's Office

By |2021-03-10T10:18:08-05:00March 9th, 2021|Categories: News|0 Comments

Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Published December 2020 as part of Aculabs’ LabTalk quarterly newsletter. Aculabs will be offering a Reticulocyte Comprehensive Panel – the panel can provide comprehensive information needed by physicians to assess the rate of red cell production and hemoglobinization. Reticulocyte count (RET #, %) indicates the quantity of circulating reticulocytes. The Immature Reticulocyte Fraction (IRF) indicates

By |2020-12-29T15:52:56-05:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Letter from the Director: Understanding Antibody Testing Provided by Aculabs

Antibodies are proteins produced by the immune system in response to infection, often within the first week of post-symptoms onset. There are several forms of antibodies: IgG, IgM, IgA, as well as other forms. However, not all antibodies are created equal; some are considered to be binding antibody and some are neutralizing. A neutralizing

By |2021-01-26T10:25:55-05:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Understanding Antibody Testing Provided by Aculabs

Official Aculabs Response to BinaxNOW Pilot Program

Aculabs would like to take this time to update all client facilities regarding a number of key issues that our industry faces in the coming week(s). Please take a moment to read the following measures. 2 Week Testing Pilot and BinaxNOW Test Cards November 20th, 2020 - The State of New Jersey

By |2020-12-16T09:05:35-05:00November 20th, 2020|Categories: News|0 Comments

Improving the Accuracy of Collection Info & Turnaround Times

In reviewing our turnaround times for our various COVID-19 testing options, it recently came to our team's attention that some client facilities are not inputting in the proper Collection Date and Time.  The collection date and time are taken from the COLLECTION DATE and COLLECTION TIME fields from the web portal when placing an order.

By |2020-11-20T17:31:24-05:00October 8th, 2020|Categories: News|0 Comments
Go to Top